GlassScriptPhysician profile
Cherie L Morris
NPI 1174550321
$1,307.41
in general payments reported to CMS, 2019-2025
18 companies · $91.17 in 2025
The $91.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $253 · 2021: $298 · 2022: $243 · 2023: $161 · 2024: $145 · 2025: $91.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $480.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $313.53 | 2019-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $130.59 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.57 | 2019-2023 | Eliquis |
| Electromed, INC. | $43.33 | 2022-2023 | Smartvest |
| Insulet Corporation | $38.24 | 2024 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $33.03 | 2024 | Airsupra, Farxiga |
| Astellas Pharma US INC | $31.77 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $25.79 | 2021 | |
| Amarin Pharma, INC. | $24.98 | 2021 | |
| Abbvie INC. | $19.82 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.68 | 2021 | |
| Medline Industries LP | $17.43 | 2024 | |
| Medtronic, INC. | $15.36 | 2025 | Intellis Adaptivestim |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.96 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.46 | 2021 | |
| Phathom Pharmaceuticals, INC. | $12.02 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherie Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.